Macquarie Group’s CytomX Therapeutics CTMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,134
| Closed | -$2 | – | 1951 |
|
|
2024
Q1 | $2 | Buy |
+1,134
| New | +$2 | ﹤0.01% | 1844 |
|
|
2021
Q4 | – | Sell |
-4,853
| Closed | -$25K | – | 2611 |
|
|
2021
Q3 | $25K | Buy |
4,853
+4,064
| +515% | +$20.9K | ﹤0.01% | 2399 |
|
|
2021
Q2 | $5K | Hold |
789
| – | – | ﹤0.01% | 2524 |
|
|
2021
Q1 | $6K | Sell |
789
-374
| -32% | -$2.84K | ﹤0.01% | 2435 |
|
|
2020
Q4 | $8K | Hold |
1,163
| – | – | ﹤0.01% | 2322 |
|
|
2020
Q3 | $8K | Hold |
1,163
| – | – | ﹤0.01% | 2297 |
|
|
2020
Q2 | $10K | Buy |
+1,163
| New | +$10K | ﹤0.01% | 2283 |
|
|
2018
Q3 | – | Sell |
-700
| Closed | -$16K | – | 2175 |
|
|
2018
Q2 | $16K | Buy |
+700
| New | +$16K | ﹤0.01% | 2085 |
|
|
2018
Q1 | – | Sell |
-22,000
| Closed | -$464K | – | 2209 |
|
|
2017
Q4 | $464K | Buy |
22,000
+16,100
| +273% | +$340K | ﹤0.01% | 1462 |
|
|
2017
Q3 | $107K | Buy |
+5,900
| New | +$107K | ﹤0.01% | 1904 |
|